Kiwa Bio-Tech Reports Third Quarter Results

* Reuters is not responsible for the content in this press release.

Thu Nov 12, 2009 9:03am EST

BEIJING and CLAREMONT, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech
Products Group Corporation (OTCBB:KWBT) announced results for the third quarter
and for the first nine months of 2009.

Revenues for the third quarter of 2009 were $1,374,561 a decrease of 40.9% from
revenues of $2,327,315 in the third quarter of 2008. This decrease was in part
due to deliberate reduction in sales of low margin bio-fertilizer and bio-feed
products. In addition, the Company's efforts in boosting sales revenue were
partially offset by requests to customers of cash payment at the time of
purchase.

During the three months ended September 30, 2009, cost of sales was $1,351,838,
representing a decrease of $919,934 or 40.5%, compared with $2,271,772 for the
same period of 2008. The sharp decrease of cost of sales was mainly attributable
to reduction of revenue.

Net loss, attributable to Kiwa shareholders, for the third quarter of 2009 was
$516,933 compared to a net loss, attributable to Kiwa shareholders, of $567,770
in the same period of 2008.

Revenues for the first nine months of 2009 were $2,864,253 compared to
$7,539,083 in the first nine months of 2008. During the nine months ended
September 30, 2009, net loss attributable to Kiwa's shareholders was $1,962,356,
an increase of $77,370 or 4.1%, compared with $1,884,986 for the same period of
2008.

Please refer to documents filed with the Securities and Exchange Commission for
additional information on the results for the third quarter and first nine
months of 2009.

Mr. Wei Li, Chairman and CEO of Kiwa, noted, "We remain focused on strengthening
manufacturing and marketing resources to develop our various business segments
and product lines. The Company also continues to seek to secure financing that
will provide flexibility in building our business and improve the balance
sheet."

ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION

The Company develops, manufactures, distributes and markets innovative,
cost-effective, and environmentally safe bio-technological products for
agricultural and natural resources and environmental conservation. The Company's
products are designed to enhance the quality of human life by increasing the
value, quality and productivity of crops and decreasing the negative
environmental impact of chemicals and other wastes. For more information about
the Company, please review documents filed with the SEC (www.sec.gov) or visit
the Company's website, www.kiwabiotech.com.

This press release contains information that constitutes forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Any such forward-looking statements involve risk
and uncertainties that could cause actual results to differ materially from any
future results described by the forward-looking statements. Risk factors that
could contribute to such differences include those matters more fully disclosed
in the Company's reports filed with the Securities and Exchange Commission. The
forward-looking information provided herein represents the Company's estimates
as of the date of the press release, and subsequent events and developments may
cause the Company's estimates to change. The Company specifically disclaims any
obligation to update the forward-looking information in the future. Therefore,
this forward-looking information should not be relied upon as representing the
Company's estimates of its future financial performance as of any date
subsequent to the date of this press release.

-0-
CONTACT: Kiwa Bio-Tech Products Group Corporation
         Yvonne Wang
         (626) 715-5855
         kiwabiotech@gmail.com

         Equity Communications
         Robert Schechter
         212-499-6809
         ir4kiwa@hotmail.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.